Is That Rush for a Third Booster Jab Necessary?
Thanks to a valued community member, TrialSite shares recent study results led by Spanish researchers. With important results published in Frontiers in Cellular and Infection Microbiology,…
Tag: Variants
Do Vaccines Diminish COVID-19 Genomic Diversity?
An interesting, some might suggest provocative, study emerged recently on the preprint server medRxiv that offers possibly some promising news. Of course, not peer-reviewed hence…
Marinomed Biotech AG announces positive data demonstrating Carragelose efficacy against SARS-CoV-2 variants
Marinomed Biotech AG (VSE:MARI), an Austrian science-based biotech company with globally marketed therapeutics derived from innovative proprietary technology platforms, announced today that Carragelose inactivates the…
Variant-Intensive Wave Wreaks Havoc on India’s Health System: Perhaps the Biggest Challenge in Modern Indian History
Mass cremations, terrified family members, and souls released before their time become ever more common as each day of this second wave of the pandemic…
NIAID-Led Study Indicates SARS-CoV-2 Specific CD8+T Cell Responses Generally Effective Against Variants But More Study Needed
The National Institute of Allergy and Infectious Diseases (NIAID) recently announced promising results from a small but important study involving 30 recovered COVID-19 patients infected…
Washington University School of Medicine Study Reveals COVID-19 Vaccines & mAbs Less Effective Against South African & Brazilian Variants
Recent research from the Washington University School of Medicine in St. Louis suggests that dangerous, new, fast spreading SARS-CoV-2 variants can avoid antibodies that work…
Broad Institute & UBC Researchers Develop COVID-19 Tracking Tool to Help Identify Mutations by Geography
A research team from the Broad institute, the University of British Columbia and 4Fusion Genomics Corporation have developed an open, free public browser resource for tracking COVID-19 virus…
Moderna Announces Strategies & Updates Associated with Variant-Specific Vaccine while Forecasting $18.4b in Revenue
Moderna Inc. (Nasdaq: MRNA), the biotechnology company with one of the authorized vaccines for COVID-19, completed the manufacturing of clinical trial material for its variant-specific…
SARS-CoV-2 Mutation and Vaccine Efficacy
In a January 25 piece in the New York Times, “As Virus Grows Stealthier, Vaccine Makers Reconsider Battle Plans,” they posit that the Moderna and…
LA Times Writer Educates Readers About the Dangers of Mutant SARS-CoV-2 Variants: TrialSite Suggests Far Better Global Coordination
TrialSite has reported that the two approved COVID-19 vaccines in the U.S. (Moderna and Pfizer/BioNTech) lose some of their effectiveness against the South African SARS-CoV-2…